Orchid Pharma reports standalone net loss of Rs 26.02 crore in the June 2021 quarter
Sales decline 19.73% to Rs 95.54 crore
Net Loss of Orchid Pharma reported to Rs 26.02 crore in the quarter ended June 2021 as against net loss of Rs 19.63 crore during the previous quarter ended June 2020. Sales declined 19.73% to Rs 95.54 crore in the quarter ended June 2021 as against Rs 119.02 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales95.54119.02 -20 OPM %1.9418.76 -PBDT-5.9110.01 PL PBT-26.02-19.63 -33 NP-26.02-19.63 -33Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content